SCHEMBL4058944

SCHEMBL4058944

NS(=O)(=O)c1ccc(Nc2ncc(Br)c(NCCN3CCNC3=O)n2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 5/20 0.57
CDK1 P06493 7/20 0.51
CDK2 P24941 7/20 0.51
KDR P35968 5/20 0.51
CDK4 P11802 4/20 0.51
CDK9 P50750 4/20 0.51
CDK7 P50613 3/20 0.51
CCNT1 O60563 3/20 0.51
CCND1 P24385 3/20 0.51
CCNH P51946 1/20 0.51
PTK2 Q05397 3/20 0.51
CCNE1 P24864 4/20 0.50
CA1 P00915 2/20 0.50
CA9 Q16790 2/20 0.50
CCNB1 P14635 1/20 0.50
NTRK1 P04629 3/20 0.49
TYK2 P29597 3/20 0.49
NUAK1 O60285 2/20 0.49
STK16 O75716 2/20 0.49
CSNK2A2 P19784 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3873384 0.83 CA2 (0.62) CA2CDK1CDK2KDRCDK4
SCHEMBL4062164 0.83 NTRK1 (0.63) CA2CDK1CDK2KDRCDK4
SCHEMBL4020350 0.80 CDK1 (0.47) CA2CDK1CDK2KDRCDK4
SCHEMBL3873057 0.80 CA2 (0.60) CA2CDK1CDK2KDRCDK4
SCHEMBL4063392 0.79 CA2 (0.57) CA2CDK1CDK2KDRCDK4
SCHEMBL4061169 0.78 CA2 (0.70) CA2CDK1CDK2KDRCDK4
SCHEMBL3873050 0.78 STK17A (0.73) CA2CDK1CDK2KDRCDK4
SCHEMBL3865620 0.77 STK17A (0.68) CA2CDK1CDK2KDRCDK4
Hydrochloric Acid SCHEMBL3869305 0.77 STK17A (0.71) CA2CDK1CDK2KDRCDK4
SCHEMBL1916973 0.76 PTK2 (0.48) CDK2PTK2CHEK1AURKARPS6KA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1392662-B1 CDK INHIBITING PYRIMIDINES, PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS BAYER SCHERING PHARMA AG (DE) 2009-01-07 EP disclosed